Cancer Health Treatment Update Tailored Light Therapy Improves Sleep Quality for Breast Cancer Survivors Customizing bright light therapy for breast cancer survivors resulted in less fatigue and better sleep. Some Recurrent Early Breast Tumors May Be New Primary Cancer Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment. News from the American Association for Cancer Research Annual Meeting See all our reports from this major cancer research conference. Advertisement Overcoming Malnutrition Medical nutrition therapy provided by a registered dietitian reduces the risk of malnutrition and improves outcomes during cancer treatment. How the Test-to-Treat Pillar of the U.S. COVID Strategy Is Failing Patients Paxlovid and molnupiravir can reduce the risk of severe COVID-19, but they must be started within five days of symptom onset. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2022 Check out our latest print edition! Newsfeed Tailored Light Therapy Improves Sleep Quality for Breast Cancer Survivors FDA Authorizes First COVID-19 Breathalyzer Test Suicide Rates Are 85% Higher in People With Cancer Jon Batiste Secretly Married Partner After Her Cancer Returned Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia Newsfeed Tailored Light Therapy Improves Sleep Quality for Breast Cancer Survivors FDA Authorizes First COVID-19 Breathalyzer Test Suicide Rates Are 85% Higher in People With Cancer Jon Batiste Secretly Married Partner After Her Cancer Returned Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: